Evolent Health (EVH) Income from Continuing Operations (2014 - 2026)

Evolent Health's Income from Continuing Operations history runs 13 years deep, the most recent figure standing at 26622000.0 for Q1 2026.

• On a quarterly basis, Income from Continuing Operations rose 58.8% year-over-year to 26622000.0 in Q1 2026; TTM through Mar 2026 was 496491000.0, a 355.39% decrease from a year earlier, with the FY2025 full-year figure at 534536000.0, down 767.43% from the prior year.
• Income from Continuing Operations improved to 26622000.0 in Q1 2026 per EVH's latest filing, from 429108000.0 in the prior quarter.
• Across five years, Income from Continuing Operations topped out at 2123000.0 in Q3 2022 and bottomed at 429108000.0 in Q4 2025.
• The 5-year median for Income from Continuing Operations is 20864000.0 (2025), against an average of 44380058.82.
• Across the five-year window, Income from Continuing Operations soared 116.32% in 2022 and tumbled 1781.23% in 2025, its largest moves.
• Year by year, Income from Continuing Operations stood at 11325000.0 in 2022, then plunged by 194.71% to 33376000.0 in 2023, then jumped by 31.66% to 22810000.0 in 2024, then tumbled by 1781.23% to 429108000.0 in 2025, then surged by 93.8% to 26622000.0 in 2026.
• Per Business Quant, the three latest EVH Income from Continuing Operations figures stand at 26622000.0 (Q1 2026), 429108000.0 (Q4 2025), and 20864000.0 (Q3 2025).